Thomas Story & Son’s Labcorp LH Stock Holding History

Thomas Story & Son’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-40,973	Closed	-$3.52M	–	63
2013 Q2	$3.52M	Buy	+40,973	New	+$3.4M	2.2%	20

Other funds holding LH

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Thomas Story & Son's LH Position: Q3 2013 in Review

Thomas Story & Son sold out of Labcorp (LH) in Q3 2013, closing a stake of 40,973 shares — an estimated $3.52M sold.

Thomas Story & Son first reported a position in LH in Q2 2013 and held it in 1 quarter. The position peaked at $3.52M in Q2 2013. 498 funds tracked by Wall St. Rank hold LH as of Q3 2013.

Thomas Story & Son reported no remaining Labcorp position as of Q3 2013 after selling out during the quarter.
Thomas Story & Son sold 40,973 Labcorp shares in Q3 2013, an estimated $3.52M.
Thomas Story & Son first reported a position in Labcorp in Q2 2013 and held it in 1 quarter.
Thomas Story & Son's Labcorp position peaked at $3.52M in Q2 2013.
498 funds tracked by Wall St. Rank held Labcorp as of Q3 2013.

Based on Thomas Story & Son's 13F filing for Q3 2013, filed 1 Nov 2013.